Skip to content

Dogwood Therapeutics DWTX Debt Conversion Original Debt Amount1

Debt Conversion Original Debt Amount1 at other companies

KLR
Kalaris Therapeutics, Inc. Common StockKLRS
$20.8M
3D Systems logo
3D SystemsDDD
$7.69M
Dogwood Therapeutics logo
Dogwood TherapeuticsDWTX
$19.5M
Falcon's Beyond Global logo
Falcon's Beyond GlobalFBYD
$5.07M
Xponential Fitness logo
Xponential FitnessXPOF
$0-100%
QT Imaging Holdings, Inc. logo
QT Imaging Holdings, Inc.QTI
$6.25K

Other financials

Income statement

See full
Operating income-$5.1M-14.6%
Net income-$5.0M+54.4%
EPS (diluted)-$0.15+98.2%

Balance sheet

See full
Cash & equivalents$13.2M-24.6%
Total debt$144.9K-24.2%
Total equity$80.6M+1,038%
Total assets$95.2M-1.8%

Cash flow

See full
Operating cash flow-$4.6M+2.0%

Valuation

See full
Market cap$54.14M-57.6%
Enterprise value$41.06M-64.7%

Returns & leverage

See full
Return on equity-64.6%-29.8pp
Debt / equity0.0×
Current ratio5.9×-1.6×

Where this comes from

Reported directly by Dogwood Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:DebtConversionOriginalDebtAmount1.

The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's debt conversion original debt amount1.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dogwood Therapeutics's debt conversion original debt amount1?
Dogwood Therapeutics (DWTX) reported debt conversion original debt amount1 of $19.5M in Q1 2025.
What does debt conversion original debt amount1 mean?
Reflects the principal amount of debt that has been converted into equity instruments, such as common stock. This non-cash activity is a significant indicator of balance sheet deleveraging and changes in capital structure. It highlights the company's strategy to reduce interest obligations by swapping debt for ownership stakes.